Nectar Lifesciences has informed that the adjourned meeting of the Board of Directors of the company will be held on Tuesday, June 27, 2017 to consider and approve the Audited Financial Results for the Financial Year 2016-17, Financial Statements of the Company for the Financial Year 2016-17 and matters related thereto; Recommendation of final dividend to the Members of the Company for Financial Year 2016-17. The Original Meeting was held on May 30, 2017 and adjourned for above matters due to certain exigencies. Further, pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Company has informed that the trading window of the Company shall stand closed from today to June 29, 2017.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: